DNA-PK is Activated by SIRT2 Deacetylation to Promote DNA Double-Strand Break Repair by Non-Homologous End Joining
PamelaSara E. Head,Priya Kapoor-Vazirani,Nagaraju P. Ganji,Hui Zhang,Sandip K. Rath,Nho C. Luong,Ramona Haji-Seyed-Javadi,Fatmata Sesay,Shi-Ya Wang,Duc M. Duong,Waaqo Daddacha,Elizabeth Minten,Boying Song,Diana Danelia,Xu Liu,Shuyi Li,Eric A. Ortlund,Nicholas T. Seyfried,David M. Smalley,Ya Wang,Xingming Deng,William S. Dynan,Bassel El-Rayes,Anthony J. Davis,David S. Yu
DOI: https://doi.org/10.1093/nar/gkad549
IF: 14.9
2023-01-01
Nucleic Acids Research
Abstract:DNA-dependent protein kinase (DNA-PK) plays a critical role in non-homologous end joining (NHEJ), the predominant pathway that repairs DNA double-strand breaks (DSB) in response to ionizing radiation (IR) to govern genome integrity. The interaction of the catalytic subunit of DNA-PK (DNA-PKcs) with the Ku70/Ku80 heterodimer on DSBs leads to DNA-PK activation; however, it is not known if upstream signaling events govern this activation. Here, we reveal a regulatory step governing DNA-PK activation by SIRT2 deacetylation, which facilitates DNA-PKcs localization to DSBs and interaction with Ku, thereby promoting DSB repair by NHEJ. SIRT2 deacetylase activity governs cellular resistance to DSB-inducing agents and promotes NHEJ. SIRT2 furthermore interacts with and deacetylates DNA-PKcs in response to IR. SIRT2 deacetylase activity facilitates DNA-PKcs interaction with Ku and localization to DSBs and promotes DNA-PK activation and phosphorylation of downstream NHEJ substrates. Moreover, targeting SIRT2 with AGK2, a SIRT2-specific inhibitor, augments the efficacy of IR in cancer cells and tumors. Our findings define a regulatory step for DNA-PK activation by SIRT2-mediated deacetylation, elucidating a critical upstream signaling event initiating the repair of DSBs by NHEJ. Furthermore, our data suggest that SIRT2 inhibition may be a promising rationale-driven therapeutic strategy for increasing the effectiveness of radiation therapy.